| Symbol | MMM |
|---|---|
| Name | 3M CO |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Surgical & Medical Instruments & Apparatus |
| Address | 3M CENTER, ST PAUL, MN 55144-1000 |
| Telephone | 6517331110 |
| Fax | — |
| — | |
| Website | https://www.3m.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0000066740 |
| Description | 3M is a multinational conglomerate that has operated since 1902 when it was known as Minnesota Mining and Manufacturing. The company is well-known for its research and development laboratory, and the firm leverages its science and technology across multiple product categories. As of 2020, 3M is organized into four business segments: safety and industrial, transportation and electronics, healthcare, and consumer. Nearly 50% of the companys revenue comes from outside the Americas, with the safety and industrial segment constituting a plurality of the firms net sales. Many of the companys 60,000-plus products touch and concern a variety of consumers and end markets. Additional info from NASDAQ: |
Director Sweet Thomas W 🟢 acquired 1.4K shares of 3M CO (MMM) at $143.34 Transaction Date: May 12, 2026 | Filing ID: 000218
Read moreDirector Kereere Suzan 🟢 acquired 1.4K shares of 3M CO (MMM) at $143.34 Transaction Date: May 12, 2026 | Filing ID: 000216
Read moreDirector Chow Anne H 🟢 acquired 1.4K shares of 3M CO (MMM) at $143.34 Transaction Date: May 12, 2026 | Filing ID: 000214
Read moreDirector BROWN THOMAS K 🟢 acquired 1.4K shares of 3M CO (MMM) at $143.34 Transaction Date: May 12, 2026 | Filing ID: 000213
Read moreDirector Fitterling James R 🟢 acquired 1.4K shares of 3M CO (MMM) at $143.34 Transaction Date: May 12, 2026 | Filing ID: 000212
Read moreDirector Bozeman David P 🟢 acquired 1.4K shares of 3M CO (MMM) at $143.34 Transaction Date: May 12, 2026 | Filing ID: 000211
Read moreDirector Choi Audrey 🟢 acquired 1.4K shares of 3M CO (MMM) at $143.34 Transaction Date: May 12, 2026 | Filing ID: 000210
Read moreDirector Mitchill Neil G. JR 🟢 acquired 1.4K shares of 3M CO (MMM) at $143.34 Transaction Date: May 12, 2026 | Filing ID: 000208
Read moreDirector PIZARRO PEDRO 🟢 acquired 1.4K shares of 3M CO (MMM) at $143.34 Transaction Date: May 12, 2026 | Filing ID: 000207
Read more| Trial ID | Title | Phase | Indication | Status | Start Date | Completion Date | Source |
|---|---|---|---|---|---|---|---|
| NCT00408473 | Comparative Study of Flecainide CR and Placebo in the Early Treatment of Atrial… | Phase4 | Atrial Fibrillation | Terminated | — | — | ClinicalTrials.gov |
| NCT06725459 | NPWT Reduction Mammaplasty | Na | Healthy | Recruiting | 2024-12-17 | 2026-11-01 | ClinicalTrials.gov |
| NCT06493539 | CiNPWT Lower Extremity Amputations (Closed Incision Neagtive Pressure Wound The… | Phase1 | Wound Heal | Withdrawn | 2024-07-25 | 2025-06-30 | ClinicalTrials.gov |
| NCT05745467 | Povidone Iodine Nasal Application to Prevent Intraoperative Spread of SARS-CoV-2 | Phase4 | SARS-CoV-2 Acute Respiratory Disease | Withdrawn | 2024-07-03 | 2026-04-01 | ClinicalTrials.gov |
| NCT05983874 | A Study to Evaluate the Safety and Immunogenicity of 2 Doses of 100µg BG505 SOS… | Phase1 | Hiv | Enrolling_By_Invitation | 2024-04-16 | 2025-03-01 | ClinicalTrials.gov |
| NCT06047067 | Bioaerosol Sampling Device (BSD) Clinical Study | — | COVID-19 | Unknown | 2023-07-10 | 2024-05-19 | ClinicalTrials.gov |
| NCT04807244 | Treatment of Deep Carious Lesions With Selective Caries Removal, Partial or Ful… | Na | Irreversible Pulpitis | Unknown | 2021-04-01 | 2025-09-30 | ClinicalTrials.gov |
| NCT04560803 | Epidermal Skin Grafts to Improve Healing In Radiation Wounds | Na | Radiation Dermatitis | Recruiting | 2021-01-19 | 2028-12-01 | ClinicalTrials.gov |
| NCT04986943 | ABTHERA ADVANCE™ Use Without Wittman Patch | — | Necrotizing Pancreatitis | Completed | 2020-10-12 | 2023-03-14 | ClinicalTrials.gov |
| NCT04210505 | Nasal Decolonization of Dialysis Patients Noses | Phase4 | Staphylococcus Aureus Infection | Active_Not_Recruiting | 2020-09-29 | 2024-01-31 | ClinicalTrials.gov |
| NCT04510402 | Phase I/II Trial of Povidone-iodine (PVP-I) Nasal Swab For Preventing COVID-19 … | Phase1 | Covid19 | Unknown | 2020-08-01 | 2021-04-01 | ClinicalTrials.gov |
| NCT04026334 | Evaluation of V.A.C. VERAFLO CLEANSE CHOICE™ Dressing Using Normal Saline to Pr… | Na | Wound | Terminated | 2019-07-25 | 2020-08-28 | ClinicalTrials.gov |
| NCT03961620 | Study on the Incidence of Perioperative Hypothermia at the Surgical Area of Par… | — | Hypothermia | Completed | 2019-07-09 | 2022-02-22 | ClinicalTrials.gov |
| NCT03711097 | Effectiveness of Resin-Modified Glass Ionomer Varnish in Preventing White Spot … | Phase4 | White Spot Lesion | Withdrawn | 2019-04-22 | 2019-04-22 | ClinicalTrials.gov |
| NCT03722485 | Negative Pressure Wound Therapy With Instillation of Saline Solution Versus Col… | Na | Wounds and Injuries | Terminated | 2018-12-12 | 2022-04-19 | ClinicalTrials.gov |
| NCT03606551 | EXD-959 Orthodontic Brackets and EXD-961 Related Instruments Trial | — | Malocclusion | Unknown | 2018-06-21 | 2022-04-30 | ClinicalTrials.gov |
| NCT03274466 | Closed Incision Negative Pressure Therapy Versus Standard of Care Surgical Dres… | Na | Surgical Wound | Completed | 2017-12-05 | 2019-12-19 | ClinicalTrials.gov |
| NCT03764059 | Clinical Study of Filtek™ Bulk Fill Posterior Restorative in Class I and II Res… | Na | Dental Caries Class I | Completed | 2017-10-17 | 2019-11-14 | ClinicalTrials.gov |
| NCT06275581 | Clinical Evaluation of the Performance of a Newly Developed Glass Ionomer Resto… | Na | Tooth Wear | Terminated | 2017-06-14 | 2021-10-01 | ClinicalTrials.gov |
| NCT03175627 | Clinical Performance of Posterior Composite Tooth Fillings in Adults | Na | Dental Caries | Completed | 2017-05-10 | 2021-05-31 | ClinicalTrials.gov |
| NCT03321799 | Comparison of Negative Pressure Wound Therapy vs. Conventional Dressings for Pr… | Phase1 | Infection, Drainage | Completed | 2017-04-28 | 2025-07-11 | ClinicalTrials.gov |
| NCT03141788 | Evaluation of Clear Aligner Trays to Straighten Teeth | Na | Malocclusion | Completed | 2017-01-30 | 2019-10-09 | ClinicalTrials.gov |
| NCT02996357 | Risk Factors for Incontinence-Associated Dermatitis (IAD) in ICU Patients Suffe… | — | Irritant Contact Dermatitis | Completed | 2016-10-04 | 2017-05-31 | ClinicalTrials.gov |
| NCT02814084 | Prevena Incision Management | Na | Cardiac Event | Completed | 2016-09-13 | 2020-02-09 | ClinicalTrials.gov |
| NCT02754791 | Reducing Blood Culture Contamination: | Na | Preventing Blood Culture Contamination | Unknown | 2016-05-01 | 2017-05-01 | ClinicalTrials.gov |
| NCT02682316 | Negative Pressure Wound Therapy in Post-Operative Incision Management | Phase3 | Negative-Pressure Wound Therapy | Completed | 2016-02-01 | 2024-01-25 | ClinicalTrials.gov |
| NCT02638298 | Incisional Negative Pressure Wound Therapy for Preoperatively Irradiated Lower … | Na | Sarcoma | Completed | 2015-12-01 | 2024-07-01 | ClinicalTrials.gov |
| NCT02561013 | A Clinical Study to Assess a Compression Device in Patients With Venous Leg Ulc… | Na | Varicose Ulcer | Withdrawn | 2015-09-01 | 2016-03-01 | ClinicalTrials.gov |
| NCT02214524 | Comparison of Active and Passive Perioperative Warming Techniques in Reducing I… | Na | Hypothermia | Unknown | 2014-08-01 | 2015-01-01 | ClinicalTrials.gov |
| NCT02203591 | In Vivo Efficacy Study of Patient Preoperative Preps | Phase3 | Bacterial Reduction Post-product Application | Completed | 2014-07-01 | 2015-03-01 | ClinicalTrials.gov |
| NCT02220101 | Temperature Measurement in Surgical and Intensive Care Patients - Comparison of… | — | Hypothermia | Completed | 2014-04-01 | 2023-01-01 | ClinicalTrials.gov |
| NCT02031159 | Correlation, Accuracy, Precision and Practicability of Zero Heat Flux Temperatu… | — | Hypothermia | Completed | 2013-10-01 | 2013-12-01 | ClinicalTrials.gov |
| NCT02030002 | Evaluation of a "Flash-free" Adhesive Resin for Orthodontic Bracket Bonding | Na | Malocclusion | Completed | 2013-10-01 | 2019-12-31 | ClinicalTrials.gov |
| NCT01913041 | An Epidemiology Survey on the Incidence of Perioperative Hypothermia | — | Hypothermia | Completed | 2013-08-01 | 2014-01-01 | ClinicalTrials.gov |
| NCT01670760 | Zero Heat Flux Thermometry System Comparison Trial | Na | Body Temperature | Completed | 2013-04-01 | 2013-06-01 | ClinicalTrials.gov |
| NCT01649596 | Impact of Expanded Peri Operative Warming | Na | Hypothermia | Completed | 2012-08-01 | 2013-04-01 | ClinicalTrials.gov |
| NCT01544686 | Antimicrobial Catheter Securement Dressings for the Prevention of Cvc-related B… | Na | Bloodstream Infection | Completed | 2012-02-01 | 2015-10-01 | ClinicalTrials.gov |
| NCT01355094 | Peritoneal Vacuum Therapy to Reduce Inflammatory Response From Abdominal Sepsis… | Na | Abdominal Compartment Syndrome | Completed | 2011-06-01 | 2022-06-01 | ClinicalTrials.gov |
| NCT01417234 | Post-Market Clinical Evaluation of the Spiracur SNaP Wound Care System for Trea… | — | Trauma-related Wound | Completed | 2011-06-01 | 2012-10-01 | ClinicalTrials.gov |
| NCT01417208 | Clinical Evaluation of the SNaP Wound Care System in Promoting Healing in Chron… | — | Lower Extremity Diabetic Leg Wounds | Withdrawn | 2011-06-01 | 2012-12-01 | ClinicalTrials.gov |
| NCT01233050 | Efficacy Comparison of Two Preoperative Skin Antisepsis Preparations in Colorec… | Na | Colorectal Surgery | Completed | 2010-12-01 | 2015-02-01 | ClinicalTrials.gov |
| NCT01255865 | Comparison Study of Core Temperature Thermometry Systems | — | Thermometry Device Comparisons | Completed | 2010-12-01 | 2011-12-01 | ClinicalTrials.gov |
| NCT01382446 | Chlorhexidine Gluconate Oral Care for Adults Experiencing Trauma | Na | Ventilator Associated Pneumonia | Completed | 2010-07-01 | 2012-04-01 | ClinicalTrials.gov |
| NCT01148030 | Impact of Pre-surgical Nasal Bacterial Reduction on Postoperative Surgical Site… | — | Surgical Site Infection | Terminated | 2010-06-01 | 2012-07-01 | ClinicalTrials.gov |
| NCT01097135 | Evaluating the Effectiveness of 2 Surgical Skin Preparation Methods in Reducing… | Na | Drainage | Completed | 2010-03-01 | 2012-12-01 | ClinicalTrials.gov |
| NCT00951080 | SNaP Wound Care System Versus Traditional NPWT Device for Treatment of Chronic … | Na | Ulcers | Completed | 2009-07-01 | 2011-03-01 | ClinicalTrials.gov |
| NCT00230373 | Imiquimod 5% Cream in Plaque-type Morphea: A Pilot, Prospective Open-label Study | Phase3 | Morphea | Withdrawn | 2005-11-01 | 2007-06-01 | ClinicalTrials.gov |
| NCT00110682 | Study of Imiquimod 5% Cream in Addition to Cryotherapy in the Management of Act… | Phase4 | Keratosis | Completed | 2005-04-01 | 2006-12-01 | ClinicalTrials.gov |
| NCT00175643 | Safety and Efficacy of Imiquimod Applied in Dose-Cycle for Actinic Keratoses | Phase3 | Actinic Keratoses | Completed | 2005-02-01 | 2005-11-01 | ClinicalTrials.gov |
| NCT00193908 | Cavilon Breast Trial: Comparison of Cavilon Durable Barrier Cream to Glycerine … | Phase3 | Breast Cancer | Completed | 2004-03-01 | 2008-10-01 | ClinicalTrials.gov |
| NCT00177021 | Aldara for the Treatment of Extensive Alopecia Areata | Phase4 | Alopecia Areata | Completed | 2000-10-01 | 2002-08-01 | ClinicalTrials.gov |
| Product Name | Type | Development Stage | Therapeutic Area | Study Status | Trial ID |
|---|---|---|---|---|---|
| imiquimod | Other | Phase PHASE3 | Actinic Keratoses | COMPLETED | NCT00175643 |
| imiquimod | Other | Phase PHASE3 | Actinic Keratoses | COMPLETED | NCT00175643 |
| Aldara Cream 5% | Other | Phase PHASE4 | Alopecia Areata | COMPLETED | NCT00177021 |
| Aldara Cream 5% | Other | Phase PHASE4 | Alopecia Areata | COMPLETED | NCT00177021 |
| Imiquimod used as an adjunct to cryotherapy | Drug | Phase PHASE4 | Keratosis | COMPLETED | NCT00110682 |
| Imiquimod used as an adjunct to cryotherapy | Drug | Phase PHASE4 | Keratosis | COMPLETED | NCT00110682 |
| Radiotherapy | Drug | Phase PHASE3 | Breast Cancer | COMPLETED | NCT00193908 |
| Sorbolene | Other | Phase PHASE3 | Breast Cancer | COMPLETED | NCT00193908 |
| Cavilon (TM) Durable Barrier Cream | Other | Phase PHASE3 | Breast Cancer | COMPLETED | NCT00193908 |
| Radiotherapy | Drug | Phase PHASE3 | Breast Cancer | COMPLETED | NCT00193908 |
| Sorbolene | Other | Phase PHASE3 | Breast Cancer | COMPLETED | NCT00193908 |
| Cavilon (TM) Durable Barrier Cream | Other | Phase PHASE3 | Breast Cancer | COMPLETED | NCT00193908 |
| Duraprep Surgical Solution | Other | Approved | Drainage | COMPLETED | NCT01097135 |
| Duraprep Surgical Solution | Other | Approved | Drainage | COMPLETED | NCT01097135 |
| 3M Skin and Nasal Antiseptic | Other | Preclinical | Surgical Site Infection | TERMINATED | NCT01148030 |
| 3M Skin and Nasal Antiseptic | Other | Preclinical | Surgical Site Infection | TERMINATED | NCT01148030 |
| Bair Hugger forced air warming system | Other | Approved | Hypothermia | UNKNOWN | NCT02214524 |
| Bair Hugger forced air warming system | Other | Approved | Hypothermia | UNKNOWN | NCT02214524 |
| Bair Hugger forced air warming system | Other | Approved | Hypothermia | UNKNOWN | NCT02214524 |
| Iodine Povacrylex/74% Isopropyl Alcohol | Other | Approved | Colorectal Surgery | COMPLETED | NCT01233050 |
| 2% Chlorhexidine Gluconate/70% Isopropyl Alcohol | Other | Approved | Colorectal Surgery | COMPLETED | NCT01233050 |
| EXD-959 Bracket System | Other | Preclinical | Malocclusion | UNKNOWN | NCT03606551 |
| EXD-959 Bracket System | Other | Preclinical | Malocclusion | UNKNOWN | NCT03606551 |
| imiquimod 5% cream (Aldara) | Other | Phase PHASE3 | Morphea | WITHDRAWN | NCT00230373 |
| imiquimod 5% cream (Aldara) | Other | Phase PHASE3 | Morphea | WITHDRAWN | NCT00230373 |
| Profore | Other | Approved | Varicose Ulcer | WITHDRAWN | NCT02561013 |
| 3M™ Coban™ Custom Fit Compression System | Other | Approved | Varicose Ulcer | WITHDRAWN | NCT02561013 |
| Profore | Other | Approved | Varicose Ulcer | WITHDRAWN | NCT02561013 |
| 3M™ Coban™ Custom Fit Compression System | Other | Approved | Varicose Ulcer | WITHDRAWN | NCT02561013 |
| 3M™ Tegaderm™ CHG IV and 3M™ Tegaderm™ Advanced IV | Other | Approved | Bloodstream Infection | COMPLETED | NCT01544686 |
| 3M™ Tegaderm™ CHG IV and 3M™ Tegaderm™ Advanced IV | Other | Approved | Bloodstream Infection | COMPLETED | NCT01544686 |
| 3M™ Tegaderm™ CHG IV and 3M™ Tegaderm™ Advanced IV | Other | Approved | Bloodstream Infection | COMPLETED | NCT01544686 |
| Soluprep | Other | Approved | Preventing Blood Culture Contamination | UNKNOWN | NCT02754791 |
| Steripath | Other | Approved | Preventing Blood Culture Contamination | UNKNOWN | NCT02754791 |
| Soluprep | Other | Approved | Preventing Blood Culture Contamination | UNKNOWN | NCT02754791 |
| Steripath | Other | Approved | Preventing Blood Culture Contamination | UNKNOWN | NCT02754791 |
| Soluprep | Other | Approved | Preventing Blood Culture Contamination | UNKNOWN | NCT02754791 |
| Steripath | Other | Approved | Preventing Blood Culture Contamination | UNKNOWN | NCT02754791 |
| Soluprep | Other | Approved | Preventing Blood Culture Contamination | UNKNOWN | NCT02754791 |
| Steripath | Other | Approved | Preventing Blood Culture Contamination | UNKNOWN | NCT02754791 |
| Toothpaste | Other | Approved | Ventilator Associated Pneumonia | COMPLETED | NCT01382446 |
| Chlorhexidine gluconate | Other | Approved | Ventilator Associated Pneumonia | COMPLETED | NCT01382446 |
| Toothpaste | Other | Approved | Ventilator Associated Pneumonia | COMPLETED | NCT01382446 |
| Chlorhexidine gluconate | Other | Approved | Ventilator Associated Pneumonia | COMPLETED | NCT01382446 |
| Toothpaste | Other | Approved | Ventilator Associated Pneumonia | COMPLETED | NCT01382446 |
| Chlorhexidine gluconate | Other | Approved | Ventilator Associated Pneumonia | COMPLETED | NCT01382446 |
| Standard of care warming | Other | Approved | Hypothermia | COMPLETED | NCT01649596 |
| Warming Gown | Other | Approved | Hypothermia | COMPLETED | NCT01649596 |
| Standard of care warming | Other | Approved | Hypothermia | COMPLETED | NCT01649596 |
| Warming Gown | Other | Approved | Hypothermia | COMPLETED | NCT01649596 |
| Iodine Povacrylex/74% Isopropyl Alcohol | Other | Approved | Colorectal Surgery | COMPLETED | NCT01233050 |
| 2% Chlorhexidine Gluconate/70% Isopropyl Alcohol | Other | Approved | Colorectal Surgery | COMPLETED | NCT01233050 |
| Povidine iodine nasal swabs | Other | Phase PHASE1 | Covid19 | UNKNOWN | NCT04510402 |
| Povidine iodine nasal swabs | Other | Phase PHASE1 | Covid19 | UNKNOWN | NCT04510402 |
| Zero-heat-flux thermometry | Other | Approved | Body Temperature | COMPLETED | NCT01670760 |
| Zero-heat-flux thermometry | Other | Approved | Body Temperature | COMPLETED | NCT01670760 |
| Normal Saline | Other | Phase PHASE3 | Bacterial Reduction Post-product Application | COMPLETED | NCT02203591 |
| ChloraPrep | Other | Phase PHASE3 | Bacterial Reduction Post-product Application | COMPLETED | NCT02203591 |
| 3M CHG/IPA Prep CH | Other | Phase PHASE3 | Bacterial Reduction Post-product Application | COMPLETED | NCT02203591 |
| 3M CHG/IPA Prep C | Other | Phase PHASE3 | Bacterial Reduction Post-product Application | COMPLETED | NCT02203591 |
| Normal Saline | Other | Phase PHASE3 | Bacterial Reduction Post-product Application | COMPLETED | NCT02203591 |
| ChloraPrep | Other | Phase PHASE3 | Bacterial Reduction Post-product Application | COMPLETED | NCT02203591 |
| 3M CHG/IPA Prep CH | Other | Phase PHASE3 | Bacterial Reduction Post-product Application | COMPLETED | NCT02203591 |
| 3M CHG/IPA Prep C | Other | Phase PHASE3 | Bacterial Reduction Post-product Application | COMPLETED | NCT02203591 |
| APC II Adhesive Coated Appliance System | Other | Approved | Malocclusion | COMPLETED | NCT02030002 |
| APC Flash-Free Adhesive Coated Appliance System | Other | Approved | Malocclusion | COMPLETED | NCT02030002 |
| APC II Adhesive Coated Appliance System | Other | Approved | Malocclusion | COMPLETED | NCT02030002 |
| APC Flash-Free Adhesive Coated Appliance System | Other | Approved | Malocclusion | COMPLETED | NCT02030002 |
| Direct composite filling after selective caries removal/full pulpotomy/partial pulpotomy | Other | Approved | Irreversible Pulpitis | UNKNOWN | NCT04807244 |
| Full Pulpotomy with Biodentine™ | Other | Approved | Irreversible Pulpitis | UNKNOWN | NCT04807244 |
| Partial Pulpotomy with Biodentine™ | Other | Approved | Irreversible Pulpitis | UNKNOWN | NCT04807244 |
| Selective Caries Removal with Biodentine™ | Other | Approved | Irreversible Pulpitis | UNKNOWN | NCT04807244 |
| Direct composite filling after selective caries removal/full pulpotomy/partial pulpotomy | Other | Approved | Irreversible Pulpitis | UNKNOWN | NCT04807244 |
| Full Pulpotomy with Biodentine™ | Other | Approved | Irreversible Pulpitis | UNKNOWN | NCT04807244 |
| Partial Pulpotomy with Biodentine™ | Other | Approved | Irreversible Pulpitis | UNKNOWN | NCT04807244 |
| Selective Caries Removal with Biodentine™ | Other | Approved | Irreversible Pulpitis | UNKNOWN | NCT04807244 |
| Filtek Z250 | Other | Approved | Dental Caries | COMPLETED | NCT03175627 |
| Filtek One | Other | Approved | Dental Caries | COMPLETED | NCT03175627 |
| Filtek Z250 | Other | Approved | Dental Caries | COMPLETED | NCT03175627 |
| Filtek One | Other | Approved | Dental Caries | COMPLETED | NCT03175627 |
| Filtek Z250 | Other | Approved | Dental Caries | COMPLETED | NCT03175627 |
| Filtek One | Other | Approved | Dental Caries | COMPLETED | NCT03175627 |
| Flecainide | Other | Phase PHASE4 | Atrial Fibrillation | TERMINATED | NCT00408473 |
| Flecainide | Other | Phase PHASE4 | Atrial Fibrillation | TERMINATED | NCT00408473 |
| V.A.C. VERAFLO CLEANSE CHOICE™ dressing with Normal Saline | Other | Approved | Wound | TERMINATED | NCT04026334 |
| V.A.C. VERAFLO CLEANSE CHOICE™ dressing with Normal Saline | Other | Approved | Wound | TERMINATED | NCT04026334 |
| SNaP® Wound Care System | Other | Preclinical | Trauma-related Wound | COMPLETED | NCT01417234 |
| SNaP® Wound Care System | Other | Preclinical | Trauma-related Wound | COMPLETED | NCT01417234 |
| SNaP Wound Care System | Other | Approved | Ulcers | COMPLETED | NCT00951080 |
| Traditional NPWT System | Other | Approved | Ulcers | COMPLETED | NCT00951080 |
| SNaP Wound Care System | Other | Approved | Ulcers | COMPLETED | NCT00951080 |
| Traditional NPWT System | Other | Approved | Ulcers | COMPLETED | NCT00951080 |
| SNaP Wound Care System | Other | Approved | Ulcers | COMPLETED | NCT00951080 |
| Traditional NPWT System | Other | Approved | Ulcers | COMPLETED | NCT00951080 |
| The SpotOn system that encompasses the registration unit (3M SpotOn Control Unit), disposable sensor (3M SpotOn Control Sensor) along with the cords and electric power unit. | Other | Preclinical | Hypothermia | COMPLETED | NCT03961620 |
| The SpotOn system that encompasses the registration unit (3M SpotOn Control Unit), disposable sensor (3M SpotOn Control Sensor) along with the cords and electric power unit. | Other | Preclinical | Hypothermia | COMPLETED | NCT03961620 |
| "Stampede" VAC | Other | Approved | Abdominal Compartment Syndrome | COMPLETED | NCT01355094 |
| KCI AbThera | Other | Approved | Abdominal Compartment Syndrome | COMPLETED | NCT01355094 |
| "Stampede" VAC | Other | Approved | Abdominal Compartment Syndrome | COMPLETED | NCT01355094 |
| KCI AbThera | Other | Approved | Abdominal Compartment Syndrome | COMPLETED | NCT01355094 |
| Prevena | Other | Approved | Cardiac Event | COMPLETED | NCT02814084 |
| Bilateral Internal Mammary Artery grafts | Other | Approved | Cardiac Event | COMPLETED | NCT02814084 |
| Prevena | Other | Approved | Cardiac Event | COMPLETED | NCT02814084 |
| Bilateral Internal Mammary Artery grafts | Other | Approved | Cardiac Event | COMPLETED | NCT02814084 |
| Standard Care | Other | Phase PHASE4 | Staphylococcus Aureus Infection | ACTIVE_NOT_RECRUITING | NCT04210505 |
| Povidone-Iodine Topical Ointment | Other | Phase PHASE4 | Staphylococcus Aureus Infection | ACTIVE_NOT_RECRUITING | NCT04210505 |
| Standard Care | Other | Phase PHASE4 | Staphylococcus Aureus Infection | ACTIVE_NOT_RECRUITING | NCT04210505 |
| Povidone-Iodine Topical Ointment | Other | Phase PHASE4 | Staphylococcus Aureus Infection | ACTIVE_NOT_RECRUITING | NCT04210505 |
| Filtek™ Z350XT Universal Restorative | Other | Approved | Dental Caries Class I | COMPLETED | NCT03764059 |
| Filtek™ Bulk Fill Posterior Restorative | Other | Approved | Dental Caries Class I | COMPLETED | NCT03764059 |
| Filtek™ Z350XT Universal Restorative | Other | Approved | Dental Caries Class I | COMPLETED | NCT03764059 |
| Filtek™ Bulk Fill Posterior Restorative | Other | Approved | Dental Caries Class I | COMPLETED | NCT03764059 |
| Using ABTHERA Advance without a Wittmann Patch | Other | Preclinical | Necrotizing Pancreatitis | COMPLETED | NCT04986943 |
| Using ABTHERA Advance without a Wittmann Patch | Other | Preclinical | Necrotizing Pancreatitis | COMPLETED | NCT04986943 |
| CelluTomeTM Epidermal Harvesting System | Other | Approved | Radiation Dermatitis | RECRUITING | NCT04560803 |
| CelluTomeTM Epidermal Harvesting System | Other | Approved | Radiation Dermatitis | RECRUITING | NCT04560803 |
| Povidone Iodine 5% Soln,Top,Kit | Other | Phase PHASE4 | SARS-CoV-2 Acute Respiratory Disease | WITHDRAWN | NCT05745467 |
| Povidone Iodine 5% Soln,Top,Kit | Other | Phase PHASE4 | SARS-CoV-2 Acute Respiratory Disease | WITHDRAWN | NCT05745467 |
| Ketac Molar Quick Aplicap Glass Ionomer Restorative (control group) | Other | Approved | Tooth Wear | TERMINATED | NCT06275581 |
| Ketac Universal Aplicap Glass Ionomer Restorative (3M) (test group) | Other | Approved | Tooth Wear | TERMINATED | NCT06275581 |
| Ketac Molar Quick Aplicap Glass Ionomer Restorative (control group) | Other | Approved | Tooth Wear | TERMINATED | NCT06275581 |
| Ketac Universal Aplicap Glass Ionomer Restorative (3M) (test group) | Other | Approved | Tooth Wear | TERMINATED | NCT06275581 |
| BG505 SOSIP.664 gp140 Vaccine, Adjuvanted (3M-052 AF plus alum) Dosage | Other | Phase PHASE1 | Hiv | ENROLLING_BY_INVITATION | NCT05983874 |
| BG505 SOSIP.664 gp140 Vaccine, Adjuvanted (3M-052 AF plus alum) Dosage | Other | Phase PHASE1 | Hiv | ENROLLING_BY_INVITATION | NCT05983874 |
| Vanish XT Dental Varnish | Other | Phase PHASE4 | White Spot Lesion | WITHDRAWN | NCT03711097 |
| Vanish XT Dental Varnish | Other | Phase PHASE4 | White Spot Lesion | WITHDRAWN | NCT03711097 |
| Collagenase Ointment | Other | Approved | Wounds and Injuries | TERMINATED | NCT03722485 |
| Negative Pressure Therapy w/ instillation and dwell (NPWTi-d) | Drug | Approved | Wounds and Injuries | TERMINATED | NCT03722485 |
| Collagenase Ointment | Other | Approved | Wounds and Injuries | TERMINATED | NCT03722485 |
| Negative Pressure Therapy w/ instillation and dwell (NPWTi-d) | Drug | Approved | Wounds and Injuries | TERMINATED | NCT03722485 |
| Collagenase Ointment | Other | Approved | Wounds and Injuries | TERMINATED | NCT03722485 |
| Negative Pressure Therapy w/ instillation and dwell (NPWTi-d) | Drug | Approved | Wounds and Injuries | TERMINATED | NCT03722485 |
| Standard of Care Dressing | Other | Approved | Surgical Wound | COMPLETED | NCT03274466 |
| Closed Incision Negative Pressure Therapy (ciNPT) | Drug | Approved | Surgical Wound | COMPLETED | NCT03274466 |
| Standard of Care Dressing | Other | Approved | Surgical Wound | COMPLETED | NCT03274466 |
| Closed Incision Negative Pressure Therapy (ciNPT) | Drug | Approved | Surgical Wound | COMPLETED | NCT03274466 |
| SNaP® Wound Care System | Other | Preclinical | Lower Extremity Diabetic Leg Wounds | WITHDRAWN | NCT01417208 |
| SNaP® Wound Care System | Other | Preclinical | Lower Extremity Diabetic Leg Wounds | WITHDRAWN | NCT01417208 |
| Clear Aligner | Other | Approved | Malocclusion | COMPLETED | NCT03141788 |
| Clear Aligner | Other | Approved | Malocclusion | COMPLETED | NCT03141788 |
| The Prevena Incision Management System | Other | Phase PHASE3 | Negative-Pressure Wound Therapy | COMPLETED | NCT02682316 |
| dry gauze | Other | Phase PHASE3 | Negative-Pressure Wound Therapy | COMPLETED | NCT02682316 |
| The Prevena Incision Management System | Other | Phase PHASE3 | Negative-Pressure Wound Therapy | COMPLETED | NCT02682316 |
| dry gauze | Other | Phase PHASE3 | Negative-Pressure Wound Therapy | COMPLETED | NCT02682316 |
| The Prevena Incision Management System | Other | Phase PHASE3 | Negative-Pressure Wound Therapy | COMPLETED | NCT02682316 |
| dry gauze | Other | Phase PHASE3 | Negative-Pressure Wound Therapy | COMPLETED | NCT02682316 |
| Sterile Antimicrobial Dressings | Other | Phase PHASE1 | Infection, Drainage | COMPLETED | NCT03321799 |
| Negative Pressure Wound Therapy (NPWT) | Drug | Phase PHASE1 | Infection, Drainage | COMPLETED | NCT03321799 |
| Sterile Antimicrobial Dressings | Other | Phase PHASE1 | Infection, Drainage | COMPLETED | NCT03321799 |
| Negative Pressure Wound Therapy (NPWT) | Drug | Phase PHASE1 | Infection, Drainage | COMPLETED | NCT03321799 |
| Standard Dry Gauze Dressing | Other | Approved | Sarcoma | COMPLETED | NCT02638298 |
| Prevana Dressing | Other | Approved | Sarcoma | COMPLETED | NCT02638298 |
| Standard Dry Gauze Dressing | Other | Approved | Sarcoma | COMPLETED | NCT02638298 |
| Prevana Dressing | Other | Approved | Sarcoma | COMPLETED | NCT02638298 |
| Standard Adhesive Dressing | Other | Approved | Healthy | RECRUITING | NCT06725459 |
| Prophylactic ciNPWT | Other | Approved | Healthy | RECRUITING | NCT06725459 |
| Standard Adhesive Dressing | Other | Approved | Healthy | RECRUITING | NCT06725459 |
| Prophylactic ciNPWT | Other | Approved | Healthy | RECRUITING | NCT06725459 |
| CINPWT | Other | Phase PHASE1 | Wound Heal | WITHDRAWN | NCT06493539 |
| Standard of Care group | Other | Phase PHASE1 | Wound Heal | WITHDRAWN | NCT06493539 |
| CINPWT | Other | Phase PHASE1 | Wound Heal | WITHDRAWN | NCT06493539 |
| Standard of Care group | Other | Phase PHASE1 | Wound Heal | WITHDRAWN | NCT06493539 |